Key result
In patients with end-stage renal disease undergoing dialysis, the prevalence of atrial fibrillation was 6.7% and was significantly associated with heart failure and age over 65 years.
Why the study?
AF is common in ESRD, where competing high thromboembolic and hemorrhagic risks and limited safety data on anticoagulants pose a clinical challenge.
What is the prevalence of atrial fibrillation and the associated thromboembolic and bleeding risk scores in patients with end-stage renal disease undergoing dialysis?
Cross-Sectional (n=295)
No
What is the prevalence of atrial fibrillation and the associated thromboembolic and bleeding risk scores in patients with end-stage renal disease undergoing dialysis?
Answers are grounded in this paper and cite their sources.
This study aims to describe the prevalence of atrial fibrillation and associated risk scores in patients with end-stage renal disease on dialysis.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hawerroth et al. (2023) conducted a cross-sectional in End-stage renal disease undergoing dialysis (n=295). In patients with end-stage renal disease undergoing dialysis, the prevalence of atrial fibrillation was 6.7% and was significantly associated with heart failure and age over 65 years.
Synapse has enriched 10 related papers. Consider them for comparative context: